Radium 223 In Men With Bone Mcrpc

Daniel George, MD, of the Duke University Cancer Center, Durham, NC, discusses the use of Radium-223 in the treatment of bone metastatic castrate resistant prostate cancer at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

  • Radium-223 in men with bone mCRPC ( Download)
  • Radium 223: Counseling Patients With mCRPC ( Download)
  • Timing and Optimization of Radium 223 in Castration Resistant Prostate Cancer ( Download)
  • Radium-223 in Combination Therapy for mCRPC ( Download)
  • Bone-Targeted Therapy for Prostate Cancer: Radium-223 ( Download)
  • Radium-223 and Metastatic Prostate Cancer ( Download)
  • Radium-223 after abiraterone: symptomatic skeletal events in patients with mCRPC ( Download)
  • Role of Radium 223 in mCRPC ( Download)
  • Radium-223 in Bone-Metastatic Castration-Resistant Prostate Cancer ( Download)
  • Dr. Morris on Radium-223 Plus Docetaxel in Patients With Bone Metastasis From CRPC ( Download)
  • ERA 223 Study | Concerns for Using Radium-223 and Abiraterone ( Download)
  • Dr. Antonarakis on Sipuleucel-T Plus Radium-223 in Bone-Metastatic CRPC ( Download)
  • Dr. George on the Use of Radium-223 in Prostate Cancer ( Download)
  • Radium-223 in Advanced Disease ( Download)
  • Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com